GEVO Stock Analysis: Gevo | NASDAQ
Specialty Chemicals | NASDAQ, USA | Market Cap: 460m USD | 12M Return: -13.9% | US3743964062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.48M
Qual. Beats: 1
Rev. Trend: 94.5%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Gevo, Inc. (NASDAQ: GEVO) is a Colorado-based carbon abatement company operating across four segments: Gevo, GevoFuels, GevoRNG, and GevoND. Its product portfolio spans sustainable aviation fuel (SAF), renewable motor fuels, isobutanol, isooctane, renewable natural gas (RNG), hydrocarbons, ethylene, and protein/feed co-products from ethanol production.
The company is also active in project development, including Alcohol-to-Jet (ATJ) initiatives, anaerobic digestion projects that capture methane for RNG, and the Verity platform, which provides supply-chain tracking and verification of sustainability attributes. Originally incorporated in 2005 as Methanotech, Gevo has positioned itself around low-carbon fuel and chemical alternatives, placing it within the small-cap energy sector focused on renewable and decarbonization solutions rather than traditional fossil fuel refining.
- SAF production ramp and offtake agreements accelerate
- IRA tax credits and LCFS pricing boost fuel margins
- Capital raises dilute shares funding SAF project buildout
| Net Income: -182.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA 6.83 > 1.0 |
| NWC/Revenue: 28.09% < 20% (prev 53.79%; Δ -25.70% < -1%) |
| CFO/TA 0.06 > 3% & CFO 32.0m > Net Income -182.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (240.9m) vs 12m ago 3.53% < -2% |
| Gross Margin: 51.17% > 18% (prev 40.20%; Δ 10.98% > 0.5%) |
| Asset Turnover: 35.54% > 50% (prev 17.65%; Δ 17.89% > 0%) |
| Interest Coverage Ratio: -7.50 > 6 (EBIT TTM -157.9m / Interest Expense TTM 21.1m) |
| A: 0.11 (Total Current Assets 120.0m - Total Current Liabilities 58.8m) / Total Assets 540.2m |
| B: -1.87 (Retained Earnings -1.01b / Total Assets 540.2m) |
| C: -0.26 (EBIT TTM -157.9m / Avg Total Assets 612.7m) |
| D: 1.29 (Book Value of Equity 298.4m / Total Liabilities 231.7m) |
| Altman-Z'' = -5.73 = D |
| DSRI: 2.01 (Receivables 28.6m/7.90m, Revenue 217.8m/120.9m) |
| GMI: 0.79 (GM 40.20% / 51.17%) |
| AQI: 0.98 (AQ_t 0.29 / AQ_t-1 0.29) |
| SGI: 1.80 (Revenue 217.8m / 120.9m) |
| TATA: -0.40 (NI -182.2m - CFO 32.0m) / TA 540.2m) |
| Beneish M = -1.87 (Cap -4..+1) = B |
As of November 20, 2026, the stock is trading at USD 1.67 with a total of 3,107,159 shares traded. Over the past week, the price has changed by -10.22%, over one month by +47.79%, over three months by +8.44% and over the past year by -13.92%.
Current recommended Stop Loss: 1.40 (which is 16.2% or 2.1 ATR below the current price).
Gevo has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy GEVO.
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 5.1 | 206% |
P/S = 2.1131
P/B = 1.5047
P/EG = -0.01
Revenue TTM = 217.8m USD
EBIT TTM = -157.9m USD
EBITDA TTM = -132.3m USD
Long Term Debt = 167.8m USD (from longTermDebt, last quarter)
Short Term Debt = 994k USD (from shortTermDebt, last quarter)
Debt = 174.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 3.33m
Net Debt = 106.9m USD (calculated: Debt 174.4m - CCE 67.6m)
Enterprise Value = 567.0m USD (460.1m + Debt 174.4m - CCE 67.6m)
Interest Coverage Ratio = -7.50 (Ebit TTM -157.9m / Interest Expense TTM 21.1m)
EV/FCF = -18.48x (Enterprise Value 567.0m / FCF TTM -30.7m)
FCF Yield = -5.41% (FCF TTM -30.7m / Enterprise Value 567.0m)
FCF Margin = -14.09% (FCF TTM -30.7m / Revenue TTM 217.8m)
Net Margin = -83.68% (Net Income TTM -182.2m / Revenue TTM 217.8m)
Gross Margin = 51.17% ((Revenue TTM 217.8m - Cost of Revenue TTM 106.3m) / Revenue TTM)
Gross Margin QoQ = 57.64% (prev 42.58%)
Tobins Q-Ratio = 1.05 (Enterprise Value 567.0m / Total Assets 540.2m)
Interest Expense / Debt = 12.08% (Interest Expense 21.1m / Debt 174.4m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -124.8m (EBIT -157.9m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.04 (Total Current Assets 120.0m / Total Current Liabilities 58.8m)
Debt / Equity = 0.58 (Debt 174.4m / totalStockholderEquity, last quarter 298.4m)
Debt / EBITDA = -0.81 (negative EBITDA) (Net Debt 106.9m / EBITDA -132.3m)
Debt / FCF = -3.48 (negative FCF - burning cash) (Net Debt 106.9m / FCF TTM -30.7m)
Total Stockholder Equity = 371.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -29.74% (Net Income -182.2m / Total Assets 540.2m)
RoE = -49.06% (Net Income TTM -182.2m / Total Stockholder Equity 371.4m)
RoCE = -29.29% (EBIT -157.9m / Capital Employed (Equity 371.4m + L.T.Debt 167.8m))
RoIC = -26.46% (negative operating profit) (NOPAT -124.8m / Invested Capital 471.5m)
WACC = 8.92% (E(460.1m)/V(634.5m) * Re(8.69%) + D(174.4m)/V(634.5m) * Rd(12.08%) * (1-Tc(0.21)))
Discount Rate = 8.69% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -5.93 | Cagr: 0.35%
[DCF] Fair Price = unknown (Cash Flow -30.7m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.04 | # QB: 1
Revenue Correlation: 94.47 | Revenue CAGR: 219.3% | SUE: 4.0 | # QB: 1
EPS current Quarter (2027-03-31): EPS=-0.01 | Chg30d=N/A | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.41 | Chg30d=+5.16% | Revisions=+0% | GrowthEPS=-195.4% | GrowthRev=+47.9%
EPS next Year (2027-12-31): EPS=0.01 | Chg30d=N/A | Revisions=+25% | GrowthEPS=+102.4% | GrowthRev=-10.2%
[Analyst] Revisions Ratio: +25% (up=1, down=0)